Market Indices


Latest News

Key Points
- Institutional investors holding positions in Eos Energy Enterprises, Inc....

April 20, 2026   EOSE 0.00%

Key Points
- Nektar Therapeutics announces successful phase 2b trial following previous...

April 20, 2026   NKTR 18.25%

ProPhase Labs, Inc. (PRPH) - This analysis reviews how the stock...

April 20, 2026   PRPH -19.90%

Natuzzi S.p.A. (NTZ) - This analysis reviews how the stock price...

April 20, 2026   NTZ -9.37%

Waterstone Financial, Inc. (WSBF) - This analysis reviews how the stock...

April 20, 2026   WSBF -0.43%


Price Targets

from Canaccord Genuity issued a price target of $13.00 for ACHV on 2026-04-20 20:20:36.The adjusted price target was set to $13.00.At the time of the announcement, ACHV...

April 20, 2026   ACHV -16.67%

from H.C. Wainwright issued a price target of $185.00 for NKTR on 2026-04-20 14:33:55.The adjusted price target was set to $185.00.At the time of the announcement, NKTR...

April 20, 2026   NKTR 18.25%

from Maxim Group issued a price target of $16.00 for LAKE on 2026-04-20 13:29:31.The adjusted price target was set to $16.00.At the time of the announcement, LAKE...

April 20, 2026   LAKE -3.30%

from Northland Securities issued a price target of $90.00 for AXTI on 2026-04-20 13:26:29.The adjusted price target was set to $90.00.At the time of the announcement, AXTI...

April 20, 2026   AXTI -4.60%

from Canaccord Genuity issued a price target of $10.50 for EVTL on 2026-04-20 11:59:35.The adjusted price target was set to $10.50.At the time of the announcement, EVTL...

April 20, 2026   EVTL -4.35%



Market Movers

Top Gainers (%)
CUE
Cue Biopharma, Inc.
0.85
40.15%
CANG
Cango Inc.
0.46
25.14%
SST
System1, Inc.
2.68
24.65%
BCAB
BioAtla, Inc.
5.69
23.97%
ATAI
Atai Beckley N.V
4.90
21.59%
NKTR
Nektar Therapeutics
100.35
18.25%
AMTX
Aemetis, Inc.
2.64
16.30%
BLNK
Blink Charging Co.
0.80
15.41%

Annual/Quarterly Reports Summary

In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...

November 6, 2024   AIP 2.26%

In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...

November 6, 2024   EOSEW -34.96%

In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...

November 6, 2024   EOSE 0.00%

In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...

November 5, 2024   STOK -2.17%

In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...

November 5, 2024   BSVN 0.14%